Skip to content

Superficial Dry Needling for Cervicogenic Headache

Superficial Dry Needling of the Trigeminal Nerve Innervation Sensory Field for Cervicogenic Headache: a Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05444296
Enrollment
133
Registered
2022-07-05
Start date
2022-07-05
Completion date
2023-12-31
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache

Brief summary

It is unknown if applying superficial dry needling to the trigeminal innervation field improves pain and disability for patients with cervicogenic headaches. The aim of this study is to determine if superficial dry needling of the trigeminal innervation field improves pain, neck mobility, and disability in patients with cervicogenic headaches. It will also be examined if psychosocial factors such as stress, anxiety, depression and self efficacy influence improvements in pain, range of motion and neck disability.

Detailed description

Cervicogenic headache (CGH), is defined by the International Classification of Headache Disorders (ICHD) as a headache caused by a disorder of the cervical spine and its component bony, disc, and/or soft tissue elements, usually but not invariably accompanied by neck pain. Prevalence of CGH in the general population is between .4-20%. Although the primary source of pain is generated from the upper cervical spinal levels, there is also neuro-anatomical basis of CGH involving the trigeminal nerve. Dry needling (DN) is a widely used intervention performed by physical therapists for a wide range of musculoskeletal and neurological conditions. Dry needling has been shown to be beneficial for CGH but DN has only been investigated using trigger point DN to cervical musculature. Superficial DN also reduces pain associated to orthopedic spinal conditions and may be associated with a lower risk of post-treatment soreness. Non-thrust mobilizations of the cervical spine are an accepted treatment known to reduce pain and disability associated with CGH. Their use has also been recommended in clinical practice guidelines. This study aims to look investigate whether superficial dry needling targeting the trigeminal innervation sensory field will reduce pain and impairments known to exist in patients with CGH compared to mobilizations of the cervical spine. Mobilizations of the cervical spine are another common treatment that physical therapists employ to treat cervicogenic headaches.

Interventions

1/2 needles will placed into defined innervation fields of the trigeminal nerve and rotated. Total time will be 5-7 minutes.

OTHERNon-thrust Mobilizations only

Non-thrust mobilizations to be applied to the most symptomatic level of the upper cervical spine as determined by a treating physical therapist. The mobilization technique will be applied for 3 bouts of 30 seconds.

Sponsors

Youngstown State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessor will be blind to the type of intervention the participant receives.

Intervention model description

Single blinded, randomized, active control

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 or older * Symptoms: (1)Unilateral pain starting in the neck and radiating to the frontotemporal region or posterior fossa, (2) pain aggravated by neck movement, (3) restricted cervical range of motion, (4) non-throbbing and non-lancinatingnpain, 5) dysfunction/headache pain in at least one of the joints of the upper cervical spine(C0-C4), and (6) headache frequency of at least 1 per week over a period greater than 3 months.

Exclusion criteria

* Headache or neck pain \<2/10 * Contraindications to the interventions * Whiplash associated disorder within 6 weeks * Pending litigation for neck pain and/or headache. * Unwilling to cease other care through duration of study

Design outcomes

Primary

MeasureTime frameDescription
Headache or neck pain intensity on a Numeric pain rating scale (0-10)<1 hour0-10 scale pain intensity, 0 is no pain, 10 is severe pain, the lower the score the better

Secondary

MeasureTime frameDescription
Active Range of Motion of the Cervical Spine in degrees of measurement<1 hourActive range of motion will be measured in the most painful and or limited plane of movement.
Patient Health Questionnaire - 9 (PHQ-9)<1 hourPatient Health Questionnaire-9 is used to assess the severity of depression an individual may have. It is scored from 1-27. The lower the score, the lower the severity of depression an individual has.
Short Form 36 (SF-36)<1 hourShort Form-36 is used to assess quality of life. Each section of the Short Form 36 is scored with weight scores from 0-100. There is specific coding per section to assess different aspects of quality of life, for example physical functioning, emotional wellbeing. 100 in each section indicates a person is functioning at the highest level possible.
Generalized Anxiety Disorder 7 (GAD-7)<1 hourGeneralized Anxiety Disorder-7 is used to assess the severity of anxiety an individual may have. The Generalized Anxiety Disorder 7 is scored from 0-21. A lower score indicates less severity of anxiety.
Flexion Rotation Test in degrees of measurement<1 hourFlexion-rotation test for CGH will be measured to determine any change in measure for c1-c2 mobility.
Headache Self Efficacy Scale (HSES)<1 hourHeadache Self Efficacy Scale is used to assess an individual's belief they can do things to prevent headaches. Higher scores indicate higher self efficacy. The items have scoring from 1-7 with 1 being strongly disagree and 7 being strongly agree. Some items are reverse scored. The scores can range from 79-121.
Injection Phobia Scale (IPS)<1 hourThe Injection Phobia Scale assesses a person's fear or anxiety toward injections. It is scored 0-32 with the higher score indicating more severity of a phobia of injections.
Severity Measure for Specific Phobia-Adult (SMSP-A)<1 hourThe Severity Measure for Specific Phobia-Adult assesses symptoms a person feels in response to injections and/or needles. It is scored 0-40 with higher scores indicating more severity of phobia of needles.
Neck Disability Index (NDI)<1 hourNeck Disability Index is used to assess how much an individual's neck pain affects daily life. The Neck Disability Index is scored from 0-50 and transformed into a percentage. This indicates the amount of disability someone has. The lower the score, the less disability is caused by neck pain.

Countries

United States

Contacts

Primary ContactDavid W Griswold, PhD
dwgriswold@ysu.edu3307015353

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026